Hims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $315.6 million versus the consensus estimate of $301.6 million.

GUIDANCE:

Hims & Hers Health, Inc. sees Q3 2024 revenue of $375-380 million, versus the consensus of $323 million.

Hims & Hers Health, Inc. sees FY2024 revenue of $1.37-1.4 billion, versus the consensus of $1.24 billion.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.